Salesforce Agentforce Life Sciences Practice Test

Salesforce Agentforce Life Sciences Consultant is a specialized AI-agent route for candidates working with life-sciences scenarios, patient and provider engagement, compliant automation, trusted data grounding, and escalation boundaries.

Use these original IT Mastery sample questions for an initial self-check. They are not official Salesforce exam questions.

What these questions test

• matching AI-agent behavior to life-sciences workflows and regulated communication boundaries
• choosing safe grounding, consent, privacy, and escalation patterns
• distinguishing patient, provider, field, and support use cases
• validating agent outputs before deployment in high-trust environments

Sample Exam Questions

Question 1

Topic: agent fit

A support team wants an agent to answer approved product-availability questions but not provide medical advice. What design is safest?

• A. Let the agent diagnose patients
• B. Ground responses in approved content and escalate medical-advice requests to the configured human process
• C. Disable all source grounding
• D. Allow the agent to invent off-label claims

Best answer: B

Explanation: Life-sciences agents need clear boundaries. Approved informational responses can be automated, but medical advice and high-risk requests should follow approved escalation.

Question 2

Topic: compliant content

An agent uses outdated prescribing-information text in a response. What should be checked first?

• A. Whether the agent has a shorter display name
• B. Whether users prefer a different color
• C. Whether audit logs can be deleted
• D. Whether the agent is grounded in current approved content and content-refresh governance

Best answer: D

Explanation: In regulated life-sciences contexts, approved-current content and refresh controls are critical. Grounding must use the right source at the right version.

Question 3

Topic: privacy

An agent may summarize patient-support interactions. What control is most important?

• A. Access permissions, data minimization, consent or authorization rules, and audit logging
• B. Public sharing of all summaries
• C. Unrestricted record access for convenience
• D. Manual copying into an unsecured spreadsheet

Best answer: A

Explanation: Patient-related context requires strict controls around access, data use, consent or authorization, and traceability.

Question 4

Topic: provider engagement

A provider asks a sales representative’s agent for product comparison claims. What should the agent rely on?

• A. Unsupported field anecdotes
• B. Competitor rumors
• C. Approved claims and current compliant source content
• D. Automatically generated claims with no review

Best answer: C

Explanation: Provider-facing product content should stay within approved claims and documented source material.

Question 5

Topic: escalation

A patient reports a serious adverse event during an agent conversation. What should happen?

• A. Ask the agent to reassure the patient and delete the chat
• B. Trigger the configured adverse-event capture and escalation process
• C. Ignore it because the conversation was automated
• D. Move the discussion to a public channel

Best answer: B

Explanation: Adverse-event handling requires strict process compliance. Agent workflows must recognize and route reportable information appropriately.

Question 6

Topic: testing

Which test set is most valuable before launching a life-sciences agent?

• A. One happy-path conversation only
• B. A test of the agent icon
• C. A list of unrelated dashboards
• D. Approved-content cases, restricted-content cases, privacy edge cases, escalation cases, and failure scenarios

Best answer: D

Explanation: Testing should prove the agent handles both normal and risky scenarios, including restricted requests and escalation triggers.

Question 7

Topic: role context

An agent should answer different questions for patients and field representatives. What should the design use?

• A. Identity, role, permission, and channel context to control response scope
• B. The same unrestricted answers for everyone
• C. Anonymous access to all data
• D. No source controls

Best answer: A

Explanation: Different audiences may have different permissions, content access, and communication rules. The agent should respect those boundaries.

Question 8

Topic: trust layer

Why should a life-sciences agent keep conversation logs and source references?

• A. To expose private data publicly
• B. To make responses less traceable
• C. To support review, auditability, quality monitoring, and issue investigation
• D. To avoid governance

Best answer: C

Explanation: Traceability is important when agent responses affect regulated communications or sensitive workflows.

Question 9

Topic: off-label request

A provider asks about an unapproved use of a product. What should the agent do?

• A. Generate a persuasive off-label claim
• B. Follow the approved medical-information or escalation workflow
• C. Ask another user for an anecdote
• D. Remove the disclosure trail

Best answer: B

Explanation: Off-label requests require controlled handling. The agent should route or respond only according to approved policy and source content.

Question 10

Topic: monitoring

After launch, quality review finds the agent sometimes omits required disclaimers. What should be reviewed?

• A. Only the button color
• B. Only the number of users
• C. Nothing after deployment
• D. Prompt instructions, source grounding, response templates, monitoring rules, and approval workflow

Best answer: D

Explanation: Required communication elements should be enforced through design, testing, and ongoing monitoring.

Question 11

Topic: data grounding

An agent answers using both approved content and a user’s unverified upload. What risk is most direct?

• A. Untrusted or unapproved content may influence regulated responses
• B. The answer will always be better
• C. Approval is no longer needed
• D. Source quality does not matter

Best answer: A

Explanation: Grounding sources need governance. Unverified content can introduce inaccurate or noncompliant statements.

Question 12

Topic: deployment governance

Who should approve a high-risk life-sciences agent before production?

• A. Any single end user
• B. The model without human review
• C. The appropriate business, compliance, security, and data owners under the release process
• D. No one if testing passed once

Best answer: C

Explanation: Higher-risk agents need cross-functional review and approval because they combine business, compliance, privacy, security, and operational risk.